|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.750 GBX | 0.00% |
|
+1.89% | -42.55% |
| 05-13 | Avingtrans subsidiary secures CE certification | AN |
| 05-12 | IXICO Plc Releases Latest Version Of AI-Driven Neuroimaging Technology Platform | CI |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.62 | 3.93 | -6.5 | -11.14 | -12.76 | |||||
Return on Total Capital | 6.98 | 4.52 | -7.23 | -12.47 | -14.72 | |||||
Return On Equity % | 15.49 | 8.61 | -9.85 | -19.15 | -15.57 | |||||
Return on Common Equity | 15.49 | 8.61 | -9.85 | -19.15 | -15.57 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.55 | 60.66 | 49.06 | 47.02 | 48.71 | |||||
SG&A Margin | 44.08 | 44.05 | 62.64 | 74.73 | 67.71 | |||||
EBITDA Margin % | 16.82 | 14.97 | -16.38 | -33.73 | -36.76 | |||||
EBITA Margin % | 13.29 | 10.93 | -20.86 | -36.13 | -38.22 | |||||
EBIT Margin % | 12.85 | 10.51 | -21.56 | -37.36 | -39.09 | |||||
Income From Continuing Operations Margin % | 17.14 | 11.94 | -17.67 | -34.7 | -25.27 | |||||
Net Income Margin % | 17.14 | 11.94 | -17.67 | -34.7 | -25.27 | |||||
Net Avail. For Common Margin % | 17.14 | 11.94 | -17.67 | -34.7 | -25.27 | |||||
Normalized Net Income Margin | 7.89 | 6.4 | -12.76 | -22.7 | -23.43 | |||||
Levered Free Cash Flow Margin | -24.37 | -13.12 | -21.29 | -27.04 | -20.39 | |||||
Unlevered Free Cash Flow Margin | -24.22 | -12.88 | -21.02 | -26.76 | -20.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.7 | 0.6 | 0.48 | 0.48 | 0.52 | |||||
Fixed Assets Turnover | 8.77 | 9.11 | 9.99 | 13.29 | 22.85 | |||||
Receivables Turnover (Average Receivables) | 4.59 | 3.56 | 4.18 | 4.47 | 4.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.51 | 5.33 | 4.91 | 2.85 | 3.03 | |||||
Quick Ratio | 4.27 | 4.9 | 4.35 | 2.51 | 2.85 | |||||
Operating Cash Flow to Current Liabilities | 0.27 | 0.82 | 0.24 | -1.1 | -0.49 | |||||
Days Sales Outstanding (Average Receivables) | 79.59 | 102.62 | 87.4 | 81.85 | 86.31 | |||||
Average Days Payable Outstanding | 52.46 | 53.03 | 18.28 | 10.12 | 8.6 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 5.32 | 4.13 | 3.39 | 3.32 | 1.52 | |||||
Total Debt / Total Capital | 5.05 | 3.97 | 3.27 | 3.21 | 1.5 | |||||
LT Debt/Equity | 4.63 | 3.15 | 2.41 | 1.58 | 0.26 | |||||
Long-Term Debt / Total Capital | 4.39 | 3.03 | 2.33 | 1.53 | 0.25 | |||||
Total Liabilities / Total Assets | 20.69 | 14.75 | 11.99 | 15.41 | 15.19 | |||||
EBIT / Interest Expense | 53.68 | 27.52 | -49.55 | -86.16 | -159.62 | |||||
EBITDA / Interest Expense | 76.59 | 42.3 | -34.14 | -73.68 | -142.31 | |||||
(EBITDA - Capex) / Interest Expense | 68.86 | 36.64 | -37.59 | -75.04 | -145.5 | |||||
Total Debt / EBITDA | 0.35 | 0.37 | -0.39 | -0.17 | -0.08 | |||||
Net Debt / EBITDA | -3.61 | -3.76 | 3.68 | 0.8 | 1.47 | |||||
Total Debt / (EBITDA - Capex) | 0.39 | 0.43 | -0.36 | -0.17 | -0.08 | |||||
Net Debt / (EBITDA - Capex) | -4.02 | -4.34 | 3.34 | 0.79 | 1.44 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.59 | -5.95 | -22.89 | -13.49 | 13.32 | |||||
Gross Profit, 1 Yr. Growth % | -5.07 | -12.96 | -37.63 | -17.09 | 17.41 | |||||
EBITDA, 1 Yr. Growth % | 46.96 | -12.74 | -184.39 | 78.11 | 22.3 | |||||
EBITA, 1 Yr. Growth % | 37.66 | -18.39 | -247.09 | 49.86 | 18.79 | |||||
EBIT, 1 Yr. Growth % | 37.97 | -18.78 | -258.26 | 49.9 | 18.57 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 65.44 | -31.75 | -214.15 | 69.86 | -17.49 | |||||
Net Income, 1 Yr. Growth % | 65.44 | -31.75 | -214.15 | 69.86 | -17.49 | |||||
Normalized Net Income, 1 Yr. Growth % | 35.2 | -19.33 | -253.79 | 53.86 | 16.95 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 56.01 | -32.33 | -220.19 | 69.76 | -55.34 | |||||
Accounts Receivable, 1 Yr. Growth % | 87.31 | -14.01 | -57.94 | 72.91 | -10.89 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.61 | -24.42 | -36.6 | -32.43 | -36.57 | |||||
Total Assets, 1 Yr. Growth % | 16.97 | 2.77 | -11.36 | -13.87 | 23.7 | |||||
Tangible Book Value, 1 Yr. Growth % | 2.26 | -9.84 | -33.15 | -40.83 | 47.39 | |||||
Common Equity, 1 Yr. Growth % | 23.05 | 8.83 | -8.49 | -17.21 | 24.02 | |||||
Cash From Operations, 1 Yr. Growth % | -68.02 | 132.3 | -78.79 | -673.51 | -41.86 | |||||
Capital Expenditures, 1 Yr. Growth % | -75.22 | 10 | -46.52 | -66 | 50 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.13K | -55.3 | 25.14 | 9.84 | -14.54 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.08K | -55.87 | 25.83 | 10.14 | -14.32 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.25 | -4.78 | -14.84 | -18.32 | -0.99 | |||||
Gross Profit, 2 Yr. CAGR % | 10.41 | -9.11 | -26.32 | -28.09 | -1.34 | |||||
EBITDA, 2 Yr. CAGR % | 83.53 | 10.91 | -14.19 | 22.6 | 48.31 | |||||
EBITA, 2 Yr. CAGR % | 77.62 | 3.22 | 9.56 | 48.47 | 34.03 | |||||
EBIT, 2 Yr. CAGR % | 80.13 | 2.99 | 13.37 | 54.02 | 33.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 90.94 | 4.12 | -11.73 | 39.25 | 18.39 | |||||
Net Income, 2 Yr. CAGR % | 90.94 | 4.12 | -11.73 | 39.25 | 18.39 | |||||
Normalized Net Income, 2 Yr. CAGR % | 78.03 | 1.56 | 11.38 | 53.82 | 34.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 84.16 | 0.75 | -9.82 | 42.84 | -12.92 | |||||
Accounts Receivable, 2 Yr. CAGR % | 16.27 | 26.92 | -39.86 | -14.72 | 24.13 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 84.96 | -10.24 | -30.78 | -34.55 | -34.53 | |||||
Total Assets, 2 Yr. CAGR % | 14.99 | 10.07 | -4.56 | -12.63 | 3.22 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.64 | -2.54 | -22.37 | -37.11 | -6.61 | |||||
Common Equity, 2 Yr. CAGR % | 19.04 | 17.05 | -0.2 | -12.96 | 1.33 | |||||
Cash From Operations, 2 Yr. CAGR % | 117.15 | -13.81 | -29.81 | 10.29 | 82.6 | |||||
Capital Expenditures, 2 Yr. CAGR % | -11.49 | -47.79 | -23.3 | -57.36 | -28.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 72.18 | 128.74 | -25.21 | 17.24 | -3.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 71.65 | 120.99 | -25.48 | 17.73 | -2.86 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 19.44 | 4.56 | -11.24 | -14.39 | -8.9 | |||||
Gross Profit, 3 Yr. CAGR % | 23.82 | 1.99 | -19.83 | -23.37 | -15.33 | |||||
EBITDA, 3 Yr. CAGR % | 32.87 | 41.27 | 1.25 | 9.46 | 22.9 | |||||
EBITA, 3 Yr. CAGR % | 20.55 | 34.66 | 16.15 | 21.62 | 38.25 | |||||
EBIT, 3 Yr. CAGR % | 14.01 | 35.62 | 18.85 | 24.43 | 41.16 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 33.1 | 33.68 | 7.36 | 9.79 | 16.96 | |||||
Net Income, 3 Yr. CAGR % | 33.1 | 33.68 | 7.36 | 9.79 | 16.96 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.52 | 34.22 | 16.62 | 24.05 | 40.39 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 15.98 | 30.19 | 6.85 | 11.35 | -3.05 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.92 | 5.15 | -12.17 | -14.49 | -13.47 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 141.24 | 37.25 | -20.06 | -31.33 | -35.23 | |||||
Total Assets, 3 Yr. CAGR % | 11.02 | 11.05 | 2.41 | -7.77 | -1.89 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.28 | 1.2 | -14.05 | -29.09 | -16.46 | |||||
Common Equity, 3 Yr. CAGR % | 15.27 | 16.41 | 7.83 | -6.23 | -2.06 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.97 | 122.09 | -45.99 | 41.37 | -10.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | 41.5 | -4.84 | -47.37 | -41.52 | -35.15 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 68.17 | 14.5 | 87.08 | -14.98 | 5.51 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 67.83 | 13.8 | 83.17 | -15.12 | 5.89 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 22.97 | 16.08 | 4.32 | -5.28 | -7.27 | |||||
Gross Profit, 5 Yr. CAGR % | 30.56 | 17.77 | 0.6 | -11.32 | -12.89 | |||||
EBITDA, 5 Yr. CAGR % | -3.18 | 0.87 | 10.63 | 33.48 | 17.95 | |||||
EBITA, 5 Yr. CAGR % | -8.19 | -6.01 | 14.8 | 40.02 | 23 | |||||
EBIT, 5 Yr. CAGR % | -11.41 | -8.7 | 12.51 | 42.7 | 24.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.76 | -7.66 | 12.01 | 35.88 | 11.64 | |||||
Net Income, 5 Yr. CAGR % | -5.76 | -7.66 | 12.01 | 35.88 | 11.64 | |||||
Normalized Net Income, 5 Yr. CAGR % | -11.72 | -9.16 | 11.41 | 41.74 | 23.34 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -18.55 | -18.68 | 4.06 | 35.11 | -1.55 | |||||
Accounts Receivable, 5 Yr. CAGR % | 20.84 | 12.5 | -12.7 | -3.3 | 0.86 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 65.15 | 68.58 | 46.41 | 2.06 | -26.2 | |||||
Total Assets, 5 Yr. CAGR % | 20.02 | 26.58 | 4.67 | 0.89 | 2.73 | |||||
Tangible Book Value, 5 Yr. CAGR % | 19.27 | 25.29 | -6.24 | -16.33 | -11.15 | |||||
Common Equity, 5 Yr. CAGR % | 22.4 | 35.96 | 9.31 | 3.63 | 5.18 | |||||
Cash From Operations, 5 Yr. CAGR % | -16.77 | 17.2 | -3.18 | 67.85 | -12.08 | |||||
Capital Expenditures, 5 Yr. CAGR % | 47.93 | 54.85 | 10.76 | -30.98 | -40.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.62 | 37.43 | 24.69 | 15.59 | 43.79 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 19.47 | 36.92 | 24.37 | 15.36 | 42.13 |
- Stock Market
- Equities
- IXI Stock
- Financials IXICO plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















